
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis
Non-invasive prenatal testing research,circulating tumor cell research,biomarkers,rare cell analysis,liquid biopsy,single cell analysis,immuno-oncology,spatial biology,clinical trials,rare cell isolation,rare cell retrieval,tissue micro-region retrieval,if microscopy,oncology,nipt,cell and gene therapy,tissue if and h&e imaging,biomarkers,multiplex imaging,and quantitative analysis
Rarecyte, inc operates in the Biotechnology research industry.
Rarecyte, inc's revenue is 11m - 100m
Rarecyte, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.